Bad Blood : Secrets and Lies in a Silicon Valley Startup
Regular price
- Unit price
- / per
Gripping account of Theranos fraud in Silicon Valley.
Bad Blood is a must-read for anyone interested in the intersection of ambition, technology, and corporate fraud. Carreyrou's book is a meticulously researched account that lays bare the details of the rise and fall of Elizabeth Holmes and Theranos. As entertaining as it is informative, Bad Blood manages to be a thrilling page-turner while also serving as a cautionary tale about the pitfalls of unchecked ambition in the tech industry.
Bad Blood : Secrets and Lies in a Silicon Valley Startup
Regular price
- Unit price
- / per
ISBN: 9781524711481
Authors:
John Carreyrou
Publisher: Penguin Random House USA
Date of Publication: 2018-05-21
Format: Paperback
Goodreads rating: 4.41
(rated by 257380 readers)
Description
The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers.In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.
Condition guide
Book Condition Guide
Books in Like New Condition
This book may contain very minor cosmetic defects, but it is in pristine condition. There should be no yellowing, no foxing, no water damage, and no annotations of any kind on the cover and the pages. For paperbacks, there should not be any crease marks on the spine. This book is good as new — lucky you!
*Books may be missing bundle media (e.g. CD, e-book code), if included.
Books in Very Good Condition
This book has been used, but it is still in a clean condition. There should be no foxing or annotations of any kind on the inner pages, but a sparse amount may be present on the cover, title pages, or outside edges of the book. There should be no water damage of any kind. For paperbacks, there may be light crease marks on the spine.
*Books may be missing bundle media (e.g. CD, e-book code), if included.
Books in Good Condition
We do our best to ensure the quality of our books, but there is no escaping the wear and tear that comes with time. Slight foxing and some annotations may be present on the pages and the cover. There should be no water damage of any kind. For paperbacks, there may be several crease marks on the spine.
*Books may be missing bundle media (e.g. CD, e-book code), if included.
Books in Well Read Condition
This is a well-read book, which means that the previous owner probably really enjoyed it! The cover and pages may include moderate foxing and annotations, but the text is not obscured and still readable. Moderate cosmetic defects and minor water damage may be present on the edges of the book. For paperbacks, there may be multiple crease marks on the spine.
*Books may be missing bundle media (e.g. CD, e-book code), if included.
Find out more about our process here.
Availability
Quantity selected exceeds current stock
Thanks for signing up for restock notifications!
There was an error signing up for restock notifications. Please try again.
Be the first to know when we restock this title!
Notify Me
Adding product to your cart
You may also like
Gripping account of Theranos fraud in Silicon Valley.
Bad Blood is a must-read for anyone interested in the intersection of ambition, technology, and corporate fraud. Carreyrou's book is a meticulously researched account that lays bare the details of the rise and fall of Elizabeth Holmes and Theranos. As entertaining as it is informative, Bad Blood manages to be a thrilling page-turner while also serving as a cautionary tale about the pitfalls of unchecked ambition in the tech industry.
You may also like
You may also like
You may also like
By completing this form, you are signing up to receive our emails and can unsubscribe at any time.